What is the recommended treatment for a Group B strep (Streptococcus agalactiae) urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Group B Streptococcus Urinary Tract Infection

First-Line Treatment Recommendation

For non-pregnant adults with symptomatic GBS UTI, treat with ampicillin 500 mg orally every 8 hours for 3-7 days, or amoxicillin 500 mg orally every 8 hours as an equally effective alternative. 1, 2

Critical Distinction: Pregnancy Status Determines Management

Pregnant vs. Non-Pregnant Patients:

  • Pregnant women: Any concentration of GBS bacteriuria (regardless of CFU count or symptoms) mandates both immediate treatment of the UTI AND intrapartum antibiotic prophylaxis during labor with penicillin G 5 million units IV initially, then 2.5-3.0 million units IV every 4 hours until delivery. 1, 2, 3

  • Non-pregnant adults: Treat only if symptomatic or if bacteriuria is ≥50,000 CFU/mL with abnormal urinalysis. Asymptomatic bacteriuria in non-pregnant patients should NOT be treated. 1, 4

This distinction is critical because the CDC guidelines for universal GBS treatment apply specifically to prevent neonatal disease and do not apply to non-pregnant individuals. 4

Treatment Algorithm by Clinical Severity

Uncomplicated UTI (non-pregnant):

  • Ampicillin 500 mg PO every 8 hours for 3-7 days 1, 2
  • Alternative: Amoxicillin 500 mg PO every 8 hours for 3-7 days 1, 2
  • All GBS strains remain fully sensitive to penicillin and ampicillin 5

Complicated UTI or Severe Infection:

  • Escalate to ampicillin 18-30 g/day IV in divided doses 1, 2
  • Alternative: Penicillin G 5 million units IV initially, then 2.5 million units IV every 4 hours 1
  • Consider initial IV therapy with ampicillin 2 g IV every 4-6 hours, then transition to oral therapy once clinically stable 4
  • Duration: 5-7 days for complicated UTI, 10-14 days for severe infections or bacteremia 1, 2

Men with possible prostatitis:

  • Extend treatment duration to 14 days to ensure adequate coverage 4

Penicillin-Allergic Patients

Non-severe penicillin allergy:

  • Cefazolin 2 g IV initial dose, then 1 g IV every 8 hours 1, 2
  • Oral alternative: Cephalexin 1

Severe penicillin allergy:

  • Clindamycin 900 mg IV every 8 hours OR 300-450 mg PO every 6-8 hours 2, 4
  • Critical caveat: Clindamycin resistance is extremely high (77.34% in recent studies), so susceptibility testing is mandatory before use. 2, 5
  • Vancomycin may be considered for severe infections with significant beta-lactam allergies 2

Essential Clinical Considerations

Obtain urine culture before treatment:

  • Confirm diagnosis with culture showing ≥50,000 CFU/mL 1, 2
  • Significant bacteriuria is defined as ≥50,000 CFU/mL of a single urinary pathogen 1, 2

Distinguish colonization from infection:

  • Asymptomatic bacteriuria in non-pregnant patients should NOT be treated to prevent antibiotic resistance 1, 4
  • Treatment of asymptomatic bacteriuria leads to unnecessary antibiotic exposure, resistance development, and potential adverse effects without clinical benefit 4

Pregnancy-specific management:

  • Women with documented GBS bacteriuria in pregnancy should NOT be re-screened in the third trimester, as they are presumed colonized 3
  • Fluoroquinolones must be avoided in pregnant patients 2

Common Pitfalls to Avoid

Underdosing or premature discontinuation:

  • Leads to treatment failure and recurrence 1
  • Ensure full course completion based on infection severity

Using clindamycin without susceptibility testing:

  • High resistance rates (77.34%) make empiric use dangerous 1, 5
  • Always confirm susceptibility before prescribing

Failing to provide intrapartum prophylaxis in pregnancy:

  • Any GBS bacteriuria during pregnancy requires intrapartum prophylaxis to prevent neonatal mortality 1, 3

Treating asymptomatic bacteriuria in non-pregnant patients:

  • This promotes antibiotic resistance without clinical benefit 1, 4
  • Only treat symptomatic infections or significant bacteriuria with abnormal urinalysis

Overlooking complicated infections:

  • GBS can cause rare but serious complications including abdominopelvic abscesses, particularly in diabetic patients 6
  • Consider imaging if severe abdominal/pelvic pain accompanies UTI symptoms

Monitoring and Follow-Up

  • Consider follow-up urine culture after treatment completion to ensure eradication, especially in complicated cases or recurrent UTIs 2, 4
  • For complicated infections or when structural abnormalities are suspected, evaluation of the urinary tract may be indicated 2

References

Guideline

Treatment of Group B Streptococcus Urinary Tract Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Beta Hemolytic Streptococcus Group B Urinary Tract Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of group B streptococcal bacteriuria in pregnancy.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2012

Guideline

Treatment of Group B Streptococcus Urinary Tract Infection in Non-Pregnant Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.